Personal CFO Solutions’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-499
Closed -$217K 493
2025
Q1
$217K Buy
+499
New +$200K 0.04% 407
2024
Q4
Sell
-686
Closed -$357K 504
2024
Q3
$357K Buy
686
+16
+2% +$8.55K 0.05% 348
2024
Q2
$363K Buy
670
+26
+4% +$13.7K 0.06% 328
2024
Q1
$334K Buy
644
+167
+35% +$83.1K 0.05% 366
2023
Q4
$225K Sell
477
-889
-65% -$411K 0.04% 458
2023
Q3
$595K Buy
1,366
+56
+4% +$25.4K 0.12% 164
2023
Q2
$582K Buy
1,310
+7
+0.5% +$3.23K 0.12% 175
2023
Q1
$599K Sell
1,303
-56
-4% -$26.6K 0.12% 158
2022
Q4
$697K Sell
1,359
-246
-15% -$125K 0.15% 136
2022
Q3
$729K Sell
1,605
-29
-2% -$13.9K 0.18% 107
2022
Q2
$788K Buy
1,634
+138
+9% +$68.3K 0.18% 94
2022
Q1
$735K Sell
1,496
-1
-0.1% -$457 0.15% 133
2021
Q4
$694K Buy
+1,497
New +$630K 0.13% 153

Other funds holding ELV

Personal CFO Solutions's ELV Position: Q2 2025 in Review

Personal CFO Solutions sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 499 shares — an estimated $217K sold.

Personal CFO Solutions first reported a position in ELV in Q4 2021 and held it in 13 quarters. The position peaked at $788K in Q2 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Personal CFO Solutions reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Personal CFO Solutions sold 499 Elevance Health shares in Q2 2025, an estimated $217K.
  • Personal CFO Solutions first reported a position in Elevance Health in Q4 2021 and held it in 13 quarters.
  • Personal CFO Solutions's Elevance Health position peaked at $788K in Q2 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Personal CFO Solutions's 13F filing for Q2 2025, filed 12 Aug 2025.